Menu

Back to Medication Guide

Valsartan

Generic Name: Valsartan

Brand Names: Diovan

Valsartan is used to treat high blood pressure, heart failure, and post-heart attack. It is available as Diovan and is commonly prescribed in the cardiovascular category.

CardiovascularARBsHypertensionHeart Failure

Side Effects

Common Side Effects:

  • Dizziness
  • Headache
  • Fatigue
  • Diarrhea
  • Arthralgia
  • Back pain

Serious Side Effects:

  • Hypotension
  • Hyperkalemia
  • Acute renal failure
  • Angioedema (rare)

Additional Information

Valsartan is an angiotensin II receptor blocker (ARB) used to treat hypertension, heart failure, and to reduce cardiovascular mortality post-myocardial infarction. It is one of the most widely prescribed ARBs.

Mechanism of Action

Valsartan blocks the renin-angiotensin system:

  • AT1 receptor antagonism: Selectively blocks angiotensin II type 1 receptors
  • Prevents vasoconstriction: Blocks angiotensin II-mediated arterial constriction
  • Reduces aldosterone secretion: Decreases sodium and water retention
  • Does not affect bradykinin: Unlike ACE inhibitors, no cough from bradykinin accumulation

Provides antihypertensive and cardioprotective effects.

Available Formulations

Valsartan is available as:

  • Tablets: 40 mg, 80 mg, 160 mg, 320 mg
  • Oral solution: 4 mg/mL

Also available in combinations with hydrochlorothiazide, amlodipine, and as part of sacubitril-valsartan (Entresto).

Medical Uses

FDA-Approved Indications:

  • Hypertension (adults and pediatric patients ≥6 years)
  • Heart failure (NYHA Class II-IV) to reduce hospitalizations
  • Post-myocardial infarction with left ventricular failure or dysfunction

Dosing Guidelines

Hypertension:

  • Initial: 80-160 mg once daily
  • Maximum: 320 mg once daily
  • Pediatric (6-16 years): 1.3 mg/kg once daily (max 40 mg)

Heart Failure:

  • Initial: 40 mg twice daily
  • Target: 160 mg twice daily
  • Titrate to highest tolerated dose

Post-MI:

  • Initial: 20 mg twice daily (may start as early as 12 hours post-MI)
  • Target: 160 mg twice daily
  • Titrate over 2 weeks as tolerated

Important Safety Information

Boxed Warning:

  • Fetal toxicity: Can cause fetal harm; discontinue when pregnancy detected

Contraindications:

  • Known hypersensitivity to valsartan
  • Concomitant use with aliskiren in patients with diabetes

Warnings and Precautions:

  • Hypotension: Risk with volume/salt depletion
  • Hyperkalemia: Monitor potassium, especially in renal impairment
  • Renal impairment: May worsen; monitor renal function
  • Hepatic impairment: Use with caution

Drug Interactions

  • Aliskiren: Contraindicated in diabetic patients; avoid in renal impairment
  • Lithium: Increased lithium levels; monitor
  • Potassium supplements/potassium-sparing diuretics: Increased hyperkalemia risk
  • NSAIDs: May reduce antihypertensive effect; increase renal dysfunction risk
  • ACE inhibitors: Dual blockade increases adverse effects

Special Populations

  • Hepatic Impairment: No adjustment for mild to moderate; use with caution in severe (especially biliary obstruction)
  • Renal Impairment: No adjustment for mild to moderate; use with caution in severe
  • Elderly: No adjustment; start at lower end of dosing range
  • Pregnancy: Contraindicated
  • Lactation: Unknown if excreted; not recommended
  • Pediatric: Approved for hypertension ≥6 years; not for children <6 or with eGFR <30

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Loading questions...

Ask Dr. Zimmer

Have questions about Valsartan? Get expert answers from Dr. Zimmer.

Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.

Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.